Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2018 | 09-2017 | 09-2016 | 09-2015 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 71,956 | 17,710 | 21,666 | 78,992 | 34,438 |
| Depreciation Amortization | 1,683 | 2,839 | 3,172 | 2,883 | 2,472 |
| Income taxes - deferred | 1,858 | -1,654 | -2,294 | 11,028 | -15,211 |
| Accounts receivable | -56,591 | 2,227 | 2,448 | -13,565 | -916 |
| Accounts payable and accrued liabilities | 1,317 | 633 | 1,451 | -543 | 399 |
| Other Working Capital | -61,787 | 21,970 | 6,171 | -16,830 | -2,258 |
| Other Operating Activity | 70,784 | 8,928 | 3,195 | 14,708 | 1,255 |
| Operating Cash Flow | $29,220 | $52,653 | $35,809 | $76,673 | $20,179 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,981 | -2,506 | -4,738 | -2,336 | -1,028 |
| Purchase Of Investment | -293,103 | -251,371 | -192,429 | -196,304 | -98,405 |
| Sale Of Investment | 260,682 | 249,305 | 153,504 | 110,617 | 99,927 |
| Other Investing Activity | 0 | 0 | 0 | -163 | 3 |
| Investing Cash Flow | $-35,402 | $-4,572 | $-43,663 | $-88,186 | $497 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -79 | -73 | -68 | 0 | 0 |
| Common Stock Issued | 6,244 | 1,079 | 1,026 | 726 | 1,054 |
| Other Financing Activity | -1,756 | 11 | 1,747 | 1,814 | 110 |
| Financing Cash Flow | $4,409 | $1,017 | $2,705 | $2,540 | $1,164 |
| Beginning Cash Position | 66,283 | 17,185 | 21,726 | 30,699 | 8,859 |
| End Cash Position | 64,510 | 66,283 | 16,577 | 21,726 | 30,699 |
| Net Cash Flow | $-1,773 | $49,098 | $-5,149 | $-8,973 | $21,840 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,220 | 52,653 | 35,809 | 76,673 | 20,179 |
| Capital Expenditure | -2,981 | -2,506 | -4,738 | -2,336 | -1,028 |
| Free Cash Flow | 26,239 | 50,147 | 31,071 | 74,337 | 19,151 |